Recruiting NA Behcet Disease

New treatment option for Behcet Disease

Official title Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

ClinicalTrials.gov ID: NCT07662603

What this study is testing

What it's testing
physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 to 17

You may be able to join if

  • adlescent patients
  • complain Behcet disease
  • after pulmonary endoarterectomy

You likely can't join if

  • chronci cardiac diseases
  • psychic disease
  • mental disease

The study team makes the final eligibility decision.

Where it's taking place

  • Giza, Dokki, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Giza, Dokki, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.